Boussard & Gavaudan Investment Management’s SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o SCPE.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-600,000
Closed -$6.12M 48
2020
Q1
$6.12M Hold
600,000
1.33% 14
2019
Q4
$6.22M Hold
600,000
1.38% 14
2019
Q3
$6.21M Buy
+600,000
New +$6.18M 0.83% 17

Other funds holding SCPE.U

Boussard & Gavaudan Investment Management's SCPE.U Position: Q2 2020 in Review

Boussard & Gavaudan Investment Management sold out of SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o (SCPE.U) in Q2 2020, closing a stake of 600,000 shares — an estimated $6.12M sold.

Boussard & Gavaudan Investment Management first reported a position in SCPE.U in Q3 2019 and held it in 3 quarters. The position peaked at $6.22M in Q4 2019. 18 funds tracked by Wall St. Rank hold SCPE.U as of Q2 2020.

  • Boussard & Gavaudan Investment Management reported no remaining SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o position as of Q2 2020 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 600,000 SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o shares in Q2 2020, an estimated $6.12M.
  • Boussard & Gavaudan Investment Management first reported a position in SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o in Q3 2019 and held it in 3 quarters.
  • Boussard & Gavaudan Investment Management's SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o position peaked at $6.22M in Q4 2019.
  • 18 funds tracked by Wall St. Rank held SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o as of Q2 2020.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q2 2020, filed 9 Jul 2020.